首页   按字顺浏览 期刊浏览 卷期浏览 Specific Factor Xa Inhibition Reduces Restenosis After Balloon Angioplasty of Atheroscl...
Specific Factor Xa Inhibition Reduces Restenosis After Balloon Angioplasty of Atherosclerotic Femoral Arteries in Rabbits

 

作者: Michael Ragosta,   Lawrence Gimple,   S. Gertz,   Christopher Dunwiddie,   George Vlasuk,   Howard Haber,   Eric Powers,   William Roberts,   Ian Sarembock,  

 

期刊: Circulation  (OVID Available online 1994)
卷期: Volume 89, issue 3  

页码: 1262-1271

 

ISSN:0009-7322

 

年代: 1994

 

出版商: OVID

 

关键词: thrombosis;antistasin;peptides;coagulation

 

数据来源: OVID

 

摘要:

BackgroundBalloon angioplasty of atherosclerotic arteries results in activation of the coagulation cascade. Several coagulation factors, including factor Xa and thrombin, are mitogenic for vascular smooth muscle cells in vitro and thus may play a role in restenosis after balloon angioplasty. Specific inhibition of factor Xa can be achieved with recombinant antistasin (rATS) or tick anticoagulant peptide (rTAP). We hypothesized that inhibition of Xa would limit restenosis after balloon angioplasty in an atherosclerotic rabbit model.Methods and ResultsFocal femoral atherosclerosis was induced by air desiccation injury and a high-cholesterol diet in 38 New Zealand White rabbits. Recombinant antistasin (n=20 arteries) or rTAP (n= 14 arteries) was administered by intravenous bolus at the time of balloon angioplasty and followed by a 2-hour infusion; controls (n=21 arteries) received bolus heparin alone (150 U/kg). Therapeutic prolongation of the activated partial thromboplastin time occurred, and antithrombotic drug levels were achieved in all animals. Luminal diameter in millimeters by quantitative angiography did not differ between treatment groups before (1.1±0.2 for controls, 1.1±0.2 for rATS, and 1.1±0.3 for rTAP) or after balloon angioplasty (1.5±0.3 for controls, 1.4±0.2 for rATS, and 1.4±0.2 for rTAP). At 28 days, treatment with factor Xa inhibitors tended to result in arteries with larger luminal diameter than controls (1.2±0.3 for rATS, 1.2±0.3 for rTAP versus 1.0±0.3 for control,P= .09 by one-way ANOVA). Restenosis, defined as reduction in angiographic luminal diameter (in mm) from 2 hours after angioplasty to 28 days after angioplasty was less in the rATS group than in controls (−0.2±0.1 versus −0.5±0.4,P< .001) and tended to be less in the rTAP group (−0.3 ±0.2 versus −0.5 +0.4,P= .07). Quantitative histopathological analysis showed less percent crosssectional area narrowing by plaque in both rATS- and rTAPtreated arteries compared with controls (42±21%, 47±18%, and 63±14%, respectively;P< .01 by one-way ANOVA).ConclusionsWe conclude that a 2-hour infusion of rATS or rTAP reduced angiographic restenosis and resulted in less luminal cross-sectional narrowing by plaque compared with controls.

 

点击下载:  PDF (4673KB)



返 回